Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC
NCT: NCT07596134 · NOT_YET_RECRUITING
Brief Summary
Multimodal Thermal Therapy combined with targeted therapy and immunotherapy versus targeted therapy and immunotherapy alone for systemically untreated unresectable hepatocellular carcinoma (HCC)
Frequently Asked Questions
What is Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC?
Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC is a clinical trial registered under NCT07596134. Current status: NOT_YET_RECRUITING.
What is the status of NCT07596134?
The current status of NCT07596134 (Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC) is: NOT_YET_RECRUITING.
When did Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC start?
Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC started on 2026-05-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.